Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advances in Diagnostic Imaging

This article was originally published in Start Up

Executive Summary

Diagnostic imaging equipment developers are using all the tools of high technology to capture images of the body's anatomical structures and to help physicians visualize the functioning of internal organ systems.

You may also be interested in...



Emageon Inc.

Only 1% of US hospitals are filmless, despite years of hype about the advantages of transmitting, viewing and storing diagnostic images digitally. Two-year-old Emageon has designed a suite of services and software that address some of the reasons hospitals are hesitant to adopt digital archiving and transmission, notably cost and technical difficulties of handling large images digitally.

Inovix Imaging Technologies Inc.

Diagnostic Imaging; Portable fluoroscopes. Inovix Imaging Technologies hopes to serve the alternate site market with, it claims, the most compact, the most portable real-time x-ray imaging system available.

Xicon Technologies LLC

Diagnostic Imaging; X-ray. Xicon Technologies hopes to catpure x-rays digitally with a system that is useful for both radiography and fluoroscopy. Xicon's imaging system makes use of the photoconductor thallium bromide to directly convert x-rays to electronic signals, without the need for an image intensifier and a camera.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036955

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel